Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates (Q42204985)
Jump to navigation
Jump to search
scientific article published on 24 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates |
scientific article published on 24 July 2014 |
Statements
1 reference
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates (English)
1 reference
Xiaodong Wang
1 reference
Matthew Hruska
1 reference
Phyllis Chan
1 reference
Alaa Ahmad
1 reference
Jeremy Freeman
1 reference
Maria Arantxa Horga
1 reference
Jan Hillson
1 reference
Vikram Kansra
1 reference
Juan-Carlos Lopez-Talavera
1 reference
24 July 2014
1 reference
1 reference
55
1 reference
1
1 reference
63-72
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference